XN000022-1996-12-04 — Page 45

43

-

Reply:

(c)

the respective amounts allocated by the HA for the purchase of antischizophrenic drugs and new antipsychotic drugs, and the respective proportions of these amounts to the total provision for the purchase of neuroleptic drugs?

In 1995/96, the amount of provision earmarked by the Hospital Authority for the purchase of neuroleptic drugs was $30.75 million, representing 3.14% of the total spending on drugs. A comparison between the average drug cost for psychiatric and non-psychiatric patients based on data obtained from the month of October 1996 is provided below -

Psychiatric Patients

Non-psychiatric Patients

Average cost per in-patient discharged

$1,119

$705

Average cost per specialist out-patient attendance

$115

$80

The amount of provision allocated for the purchase of antischizophrenic drugs and new antipsychotic drugs, as well as their respective proportions in relation to the total spending on neuroleptic drugs in 1995/96 are as follows -

Antischizophrenic drugs

New antipsychotic drugs

Expenditure ($m)

% of Total Budget for Neuroleptic Drugs

14.2

46.2%

1.89

6.1%

For 1996/97, an additional provision of $3.3 million has been earmarked specifically for the procurement of new antipsychotic drugs.

End